
UB476
ProductAmiodarone Hydrochloride Injection
Strength150mg/3mL, 450mg/9mL, 900mg/18mL
IndicationsVentricular arrhythmia; Supraventricular arrhythmia; Atrial fibrillation; Ventricular tachycardia
TherapeuticsCardiovascular
GMPUS - FDA
RegistrationUnited States
ModalitiesSmall Molecule
Exclusive Summary
- - Long off-patent with broad generic availability and US registration, enabling multi-country fast access; - Anchored in AHA/ERC resuscitation guidelines and WHO EML, ensuring steady hospital emergency demand; - Three strengths (150/3mL, 450/9mL, 900/18mL) cover bolus and maintenance infusion, reducing compounding and waste; - US registration and compliance serve as regulatory reliance and quality credentials to win tenders and distribution; - Compared with originator and premix bags, conventional vials typically deliver 30–90% price savings to drive uptake.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →